美国信息技术与创新基金会：2024年中国在生物技术领域的创新能力如何研究报告（英文版）

 Recent Chinese government policies have emphasized domestic biotech innovation. A new national strategy has been crucial to the sector’s growth.  Several factors are spurring growth, including subsidies, financial incentives, science parks, start-up incubators, talent recruitment schemes, public-private partnerships, and reforms to expedite drug review and enhance IP protection.  Indicators suggest Chinese biotech is becoming more innovative. For example, the U.S. FDA approved three new C